MARKET

QNTM

QNTM

Quantum BioPharma Ltd
NASDAQ
7.30
-0.03
-0.41%
After Hours: 7.10 -0.2 -2.74% 19:57 12/31 EST
OPEN
7.00
PREV CLOSE
7.33
HIGH
7.88
LOW
6.90
VOLUME
119.13K
TURNOVER
--
52 WEEK HIGH
38.25
52 WEEK LOW
2.890
MARKET CAP
28.05M
P/E (TTM)
-0.7073
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at QNTM last week (1222-1226)?
Weekly Report · 12/29/2025 10:20
Quantum BioPharma Completes 180-Day Toxicity Dosing for Lead MS Drug Lucid-MS
TipRanks · 12/23/2025 13:28
Quantum Group completes dosing in 180-day study of Lucid-MS
TipRanks · 12/23/2025 13:16
Quantum BioPharma Completes 180-Day Toxicity Studies for Lucid-MS
Reuters · 12/23/2025 13:00
QUANTUM BIOPHARMA ANNOUNCES COMPLETION OF DOSING IN 180-DAY REPEATED DOSE ORAL TOXICITY AND TOXICOKINETIC STUDIES FOR LUCID-21-302 (LUCID-MS)
Reuters · 12/23/2025 13:00
Quantum BioPharma Launches US$17.2 Million ATM Equity Program on Nasdaq
TipRanks · 12/22/2025 21:46
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 12/22/2025 17:05
Quantum BioPharma Shareholder Sues Canadian Imperial Bank Of Commerce, Royal Bank Of Canada, RBC Capital Markets Over Alleged Stock Manipulation
Benzinga · 12/22/2025 14:06
More
About QNTM
Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc., it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. The Company has also licensed unbuzzd, a formulation of natural ingredients, vitamins, and minerals to help with liver and brain function for the purposes of quickly relieving individuals from the effects of alcohol consumption. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.

Webull offers Quantum Biopharma Ltd stock information, including NASDAQ: QNTM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, QNTM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading QNTM stock methods without spending real money on the virtual paper trading platform.